The pharmaceutical industry is undergoing a seismic transformation, driven by the integration of data science and analytics. As the demand for novel therapies and personalized medicine surges, leaders ...
The DISRUPT-DS roundtable, which brings together data science leaders from large pharmaceutical companies, aims to be a forum for sharing experiences and networking, for shaping industry-level topics ...
A few years ago, companies did ESG reporting because they felt like they had to. Now, it's a bigger deal. The rules are getting tighter, investors are asking harder questions, and just saying you’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results